CytoSorbents Corp. (CTSO)

11.00
0.90 8.91
NASDAQ : Health Technology
Prev Close 10.10
Open 10.10
Day Low/High 10.10 / 11.10
52 Wk Low/High 3.30 / 10.90
Volume 525.19K
Avg Volume 231.80K
Exchange NASDAQ
Shares Outstanding 30.03M
Market Cap 316.84M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CytoSorbents Refinances Existing Debt With New $15 Million Debt Facility With Bridge Bank

CytoSorbents Refinances Existing Debt With New $15 Million Debt Facility With Bridge Bank

Extends the interest only period of the existing $10M debt by 18 months and adds the option for an additional $5M in debt

CytoSorbents Expands Its Partnership With Biocon To Launch CytoSorb® In Malaysia

CytoSorbents Expands Its Partnership With Biocon To Launch CytoSorb® In Malaysia

Expands upon Biocon's successful commercialization of CytoSorb in India and leverages its substantial commitment to the Malaysian market

CytoSorbents Pre-Announces Preliminary Fourth Quarter And Full Year 2017 Results And Issues Stockholder Letter

CytoSorbents Pre-Announces Preliminary Fourth Quarter And Full Year 2017 Results And Issues Stockholder Letter

CytoSorbents achieved record growth in 2017 with total revenue of more than $15 million, including CytoSorb sales of approximately $13.2 million, with the goal of achieving sustained operating profitability on a quarterly basis later this year

Cytosorbents Enters Oversold Territory (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents (CTSO)

Oversold Conditions For Cytosorbents (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapy was one of the hottest -- and most crowded -- areas within biotech in 2015. And 2016 looks promising.

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Immunotherapy was one of the hottest – and most crowded - areas within biotech in 2015.

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

4 Stocks Rising on Unusual Volume to Trade for Breakouts

4 Stocks Rising on Unusual Volume to Trade for Breakouts

These stocks rising on unusual volume are within range of triggering breakout trades.

Relative Strength Alert For Cytosorbents

Relative Strength Alert For Cytosorbents

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

These under-$10 biotech stocks are within range of triggering breakout trades.

4 Stocks Spiking on Big Volume: Arista Networks and More

4 Stocks Spiking on Big Volume: Arista Networks and More

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech columnist Adam Feuerstein answers readers' questions about health care.